A prospective observational nationwide descriptive study to determine neurologic adverse events following immunization following BNT162b2 mRNA vaccine in Mexico
Latest Information Update: 25 Aug 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 25 Aug 2021 New trial record
- 01 Aug 2021 Results published in the Clinical Immunology